Versant Venture Management
Latest statistics and disclosures from Versant Venture Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CRSP, Skye Bioscience, RPTX, GRTS, Adverum Biotechnologies, and represent 91.30% of Versant Venture Management's stock portfolio.
- Added to shares of these 1 stock: Skye Bioscience (+$31M).
- Started 1 new stock position in Skye Bioscience.
- Reduced shares in these 2 stocks: Rayzebio (-$321M), Adverum Biotechnologies (-$65M).
- Sold out of its position in Rayzebio.
- Versant Venture Management was a net seller of stock by $-354M.
- Versant Venture Management has $103M in assets under management (AUM), dropping by -73.48%.
- Central Index Key (CIK): 0001560009
Tip: Access up to 7 years of quarterly data
Positions held by Versant Venture Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 7 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| CRISPR Therapeutics Common Stock (CRSP) | 32.9 | $34M | 499k | 68.16 |
|
|
| Skye Bioscience Common Stock | 30.4 | $31M | NEW | 2.0M | 15.64 |
|
| Repare Therapeutics Common Stock (RPTX) | 12.1 | $13M | 2.6M | 4.71 |
|
|
| Gritstone Oncology Common Stock (GRTS) | 8.9 | $9.2M | 3.6M | 2.57 |
|
|
| Adverum Biotechnologies Common Stock | 6.9 | $7.2M | -90% | 507k | 14.14 |
|
| Passage Bio Common Stock (PASG) | 6.5 | $6.7M | 5.0M | 1.35 |
|
|
| Aligos Therapeutics Common Stock (ALGS) | 2.2 | $2.3M | 2.3M | 0.98 |
|
Past Filings by Versant Venture Management
SEC 13F filings are viewable for Versant Venture Management going back to 2014
- Versant Venture Management 2024 Q1 filed May 3, 2024
- Versant Venture Management 2023 Q4 filed Feb. 8, 2024
- Versant Venture Management 2023 Q3 filed Nov. 3, 2023
- Versant Venture Management 2023 Q2 filed Aug. 9, 2023
- Versant Venture Management 2023 Q1 filed May 11, 2023
- Versant Venture Management 2022 Q4 filed Feb. 9, 2023
- Versant Venture Management 2022 Q3 filed Nov. 10, 2022
- Versant Venture Management 2022 Q2 filed Aug. 11, 2022
- Versant Venture Management 2022 Q1 filed May 10, 2022
- Versant Venture Management 2021 Q4 filed Feb. 11, 2022
- Versant Venture Management 2021 Q3 filed Nov. 12, 2021
- Versant Venture Management 2021 Q2 filed Aug. 12, 2021
- Versant Venture Management 2021 Q1 filed May 7, 2021
- Versant Venture Management 2020 Q4 filed Feb. 16, 2021
- Versant Venture Management 2020 Q3 filed Nov. 12, 2020
- Versant Venture Management 2020 Q2 filed July 20, 2020